Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancer

Background: Addition of nimotuzumab to weekly cisplatin and radiation improves outcomes in head and neck cancer. HPV negative oropharyngeal cancer has unsatisfactory treatment outcomes and is a candidate for escalation of treatment. We wanted to determine whether the addition of nimotuzumab to cispl...

Descripción completa

Detalles Bibliográficos
Autores principales: Noronha, Vanita, Patil, Vijay Maruti, Joshi, Amit, Mahimkar, Manoj, Patel, Usha, Pandey, Manish Kumar, Chandrasekharan, Arun, Dsouza, Hollis, Bhattacharjee, Atanu, Mahajan, Abhishek, Sabale, Nilesh, Agarwal, Jai Prakash, Ghosh-Laskar, Sarbani, Budrukkar, Ashwini, D’Cruz, Anil K., Chaturvedi, Pankaj, Pai, Prathamesh S., Chaukar, Devendra, Nair, Sudhir, Thiagarajan, Shivakumar, Banavali, Shripad, Prabhash, Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996911/
https://www.ncbi.nlm.nih.gov/pubmed/32064043
http://dx.doi.org/10.18632/oncotarget.27443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996911/
https://www.ncbi.nlm.nih.gov/pubmed/32064043
http://dx.doi.org/10.18632/oncotarget.27443

Ejemplares similares